Methylene blue

Mblue Labs Discovers Anti-Aging Power In Methylene Blue, Launches Bluelene Face&Neck Remodel Mask

Retrieved on: 
Wednesday, March 13, 2024
Scientific Reports, Health, Skin care, ECM, Face, Retinol, Radical (chemistry), Cell nucleus, Peptide, Extracellular matrix, DNA, Research, ROS, Mitochondrion, Methylene blue, Skin, Collagen, DNA repair, UMD, Identity matrix, Human, Ageing, Neck, Cosmetics

Bethesda, Maryland--(Newsfile Corp. - March 13, 2024) - Mblue Labs proudly announces the debut of the Face & Neck Remodel Mask, a groundbreaking addition to their renowned skincare brand, Bluelene.

Key Points: 
  • Bethesda, Maryland--(Newsfile Corp. - March 13, 2024) - Mblue Labs proudly announces the debut of the Face & Neck Remodel Mask, a groundbreaking addition to their renowned skincare brand, Bluelene.
  • Mblue Labs, a woman and minority-owned business, is dedicated to advancing skincare science, and this latest product embodies their commitment to unparalleled innovation.
  • Methylene Blue penetrates skin cells at the mitochondrial level, creating cell health and proliferation.
  • To view an enhanced version of this graphic, please visit:
    The Face & Neck Remodel Mask features a powerful blend of the latest age-reversal ingredients, including Methylene Blue, Growth Factors, Advanced Peptides, and Niacinamide.

Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer

Retrieved on: 
Friday, September 8, 2023
DNA, Nano, MB, DNAS, Van der Waals, Methylene blue, Chung-Ang University, Molybdenum disulfide, Molybdenum, DPV, Carbon, Immobilization, Nanostructure, Nanodiamond, Associate, Journal, Cervical cancer, School, HPV, Diagnosis, Chemical engineering, Vaccine, Carbon fibers

SEOUL, South Korea, Sept. 8, 2023 /PRNewswire/ -- Molybdenum disulfide (MoS2) has recently garnered attention among materials science researchers owing to its ability to form two-dimensional nanosheets like graphene. The nanosheets are created by the stacking of S–Mo–S layers interacting via Van der Waals interactions. Additionally, the unique structural, optical, thermal, and electrochemical properties of MoS2 have opened up multiple research avenues across several fields, including the development of biomolecule sensing and chemical detection platforms, optoelectronics, supercapacitors, and batteries.

Key Points: 
  • Traditionally, carbon nanostructures have been employed as an immobilization platform for DNA.
  • In order to substitute carbon with MoS2 as an effective electrochemical DNA sensor, the electrical conductivity of MoS2 needs to be improved considerably.
  • The duo has developed an electrochemical DNA biosensor using a graphitic nano-onion/molybdenum disulfide (MoS2) nanosheet composite, which effectively detects human papillomavirus (HPV)-16 and HPV-18, and can serve as an early diagnosis of cervical cancer.
  • Dr. Kang elaborates: "The DPV current peak was lowered after probe DNA chemisorption and target DNA hybridization.

Italian pharmaceutical company Alfasigma launches diagnostic drug Lumeblue™ ahead of World Digestive Health on 29 May

Retrieved on: 
Friday, May 27, 2022
Department, ESGE, Physician, Colon, Risk, Endoscopy unit, Death, Disease, HD, CRC, Incidence, Health, University of Kansas School of Medicine, European Medicines Agency, ADR, Patient, Colonoscopy, Internal medicine, Mortality, Section, Artificial intelligence, Institute, Gastroenterology, Methylene blue, Awareness, EMA, III, University, Pamlab, Colorectal cancer, Adoption, Chromoendoscopy, Pharmaceutical industry, European Economic Area, EU

BOLOGNA, Italy, May 27, 2022 /PRNewswire/ -- Ahead of World Digestive Health 2022, Italian pharmaceutical group Alfasigma is proud to announce the launch of its new diagnostic drug Lumeblue™ (per-oral methylene blue). This latest innovation is part of the company's commitment to raising awareness on colorectal cancer (CRC), still the second leading cause of cancer deaths worldwide, through a healthy lifestyle and regular screenings.

Key Points: 
  • BOLOGNA, Italy, May 27, 2022 /PRNewswire/ -- Ahead of World Digestive Health 2022, Italian pharmaceutical group Alfasigma is proud to announce the launch of its new diagnostic drug Lumeblue (per-oral methylene blue).
  • Lumeblue is approved by EMA (European Medicines Agency) for the detection of lesions during colonoscopy.
  • Lumeblue was in a symposium titled "A new tool in colonoscopy: Per-oral methylene blue" at ESGE Days 2022 as a new diagnostic drug to improve the detection of lesions during colonoscopy.
  • Privately owned, Alfasigma is an Italy-based multinational pharmaceutical company with a presence in over 90 countries through distributors and subsidiaries.

COSMO ANNOUNCES EXPANDING THE AGREEMENT WITH MEDTRONIC FOR ELEVIEW(R) TO ALL COUNTRIES EXCEPT CANADA

Retrieved on: 
Tuesday, May 3, 2022
Adenoma, XETRA, Pharmaceuticals and Medical Devices Agency, Medical device, Cosmo, Endoscopy, IIA, Injection, FDA, Colon, Medtronic, Tissue, Methylene blue, PMDA, Health Canada, C43, Medicines and Healthcare products Regulatory Agency, EA, Polyp, EU

Dublin, Ireland - 3 May 2022: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) ('Cosmo') announces the expansion of the agreement with Medtronic for the distribution of Eleview(R) to all countries except Canada, following the mutual termination of the license agreement with EA Pharma.

Key Points: 
  • Dublin, Ireland - 3 May 2022: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) ('Cosmo') announces the expansion of the agreement with Medtronic for the distribution of Eleview(R) to all countries except Canada, following the mutual termination of the license agreement with EA Pharma.
  • The objective is to allow endoscopists with a faster and less risky excision of adenomas or polyps during endoscopy.
  • Eleview(R) is approved in the U.S., EU, Canada and Japan: The FDA approved the product in September 2015.
  • Eleview(R) was approved by Health Canada in 2019 and in November 2020 it was approved by Japan's Pharmaceuticals and Medical Devices Agency (PMDA).

Alofisel®▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the Real-World INSPIRE Study Interim Analysis Consistent with the Pivotal Clinical ADMIRE-CD Study1,2

Retrieved on: 
Friday, February 18, 2022
Oncology, Health, Stem Cells, Genetics, Clinical Trials, Pharmaceutical, Biotechnology, United Kingdom, NASA Astronaut Group 13, Hydrogen peroxide, Patient, Colon, Risk, Infection, Pregnancy, Department, American Society of Colon and Rectal Surgeons, TAK, CD, Fistula, AT, Adult, Safety, Sodium chloride, Shamir Medical Center, INSPIRE, PP, Woman, Anesthetic, Needle, Streptomycin, Birth, Excipient, Diagnosis, Hypersensitivity, Phase 3, Methylene blue, Pharmaceutical industry, Vaccine, Takeda, European, Darvadstrocel, Alofisel, Takeda, ALOFISEL, TAKEDA

We are delighted to present the results of the first interim analysis from the real-world multicenter INSPIRE study.

Key Points: 
  • We are delighted to present the results of the first interim analysis from the real-world multicenter INSPIRE study.
  • Alofisel should only be administered by specialist physicians experienced in the diagnosis and treatment of conditions for which Darvadstrocel is indicated.
  • Alofisel is not recommended during pregnancy and in women of childbearing potential who are not using contraception.
  • Together with researchers, patient groups and more, we are working to advance scientific research and clinical medicine in GI.

Pusan National University Scientists Enhance Durability of Lithium-Sulfur Batteries with Dyes

Retrieved on: 
Monday, February 7, 2022
Lithium, Assistant, Chemical engineering, Carbon, Engineering, Methylene blue, Plasma, Associate, Chemical substance, Zhurong (rover), Nitrogen, Pusan National University, Sulfur, Electric battery

Unfortunately, conventional lithium-ion batteries (LIBs) have almost reached their theoretical limit, and need to be supplanted by batteries with higher theoretical capacity and energy density.

Key Points: 
  • Unfortunately, conventional lithium-ion batteries (LIBs) have almost reached their theoretical limit, and need to be supplanted by batteries with higher theoretical capacity and energy density.
  • Fortunately, in a recent study, a team of scientists from Pusan National University, South Korea, found an efficient way to mitigate the shuttling effect and improve the performance of Li-S batteries.
  • Overall, this study could motivate scientists worldwide to look into other potential applications of organic dyes outside textile dyeing.
  • Let us hope these alternative uses of organic dyes help color a better and more sustainable future.

New "Solar" Catalyst to Treat Industrial Waste Water Cheap and Fast from NUST MISIS Scientists

Molybdenum trioxide, Water pollution, Temperature, Far Eastern Federal University, Carbon, Method, Sunlight, H2S, Life, FEFU, Dimethylformamide, Sulfur, Methylene blue, Water, Research, Water purification, Molybdenum(V) chloride, Environment, Molybdenum, NUST, Fudan University, Nanomaterials, Technology, Aluminium

MOSCOW, Dec. 13, 2021 /PRNewswire/ -- A new "solar" catalyst based on molybdenum sulfide for water purification was developed by NUST MISIS scientists together with colleagues from FEFU, Fudan University (China) and Tokai University (Japan).

Key Points: 
  • MOSCOW, Dec. 13, 2021 /PRNewswire/ -- A new "solar" catalyst based on molybdenum sulfide for water purification was developed by NUST MISIS scientists together with colleagues from FEFU, Fudan University (China) and Tokai University (Japan).
  • Therefore, scientists are faced with the task of minimizing the amount of harmful emissions, as well as developing effective methods for purifying water from these emissions.
  • Photocatalytic degradation by sunlight is a technology with minimal anthropogenic impact on the environment, as it uses only natural sunlight and a catalyst.
  • Therefore, with the use of non-toxic photocatalysts scientists can create a "green technology" for processing harmful emissions, similar to natural photosynthesis.

New "Solar" Catalyst to Treat Industrial Waste Water Cheap and Fast from NUST MISIS Scientists

Molybdenum trioxide, Water pollution, Temperature, Far Eastern Federal University, Carbon, Method, Sunlight, H2S, Life, FEFU, Dimethylformamide, Sulfur, Methylene blue, Water, Research, Water purification, Molybdenum(V) chloride, Environment, Molybdenum, NUST, Fudan University, Nanomaterials, Technology, Aluminium

MOSCOW, Dec. 13, 2021 /PRNewswire/ -- A new "solar" catalyst based on molybdenum sulfide for water purification was developed by NUST MISIS scientists together with colleagues from FEFU, Fudan University (China) and Tokai University (Japan).

Key Points: 
  • MOSCOW, Dec. 13, 2021 /PRNewswire/ -- A new "solar" catalyst based on molybdenum sulfide for water purification was developed by NUST MISIS scientists together with colleagues from FEFU, Fudan University (China) and Tokai University (Japan).
  • Therefore, scientists are faced with the task of minimizing the amount of harmful emissions, as well as developing effective methods for purifying water from these emissions.
  • Photocatalytic degradation by sunlight is a technology with minimal anthropogenic impact on the environment, as it uses only natural sunlight and a catalyst.
  • Therefore, with the use of non-toxic photocatalysts scientists can create a "green technology" for processing harmful emissions, similar to natural photosynthesis.

NICE Accredits Endomag’s Magtrace® Lymphatic Tracer for Staging Breast Cancer

Retrieved on: 
Wednesday, August 18, 2021
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Sentinel, NHS England, Union, Lymphatic system, Biopsy, Five Year Forward View, Government, University, National Institute for Health and Care Excellence, Cancer, Endomag, Lymph node, Kate Williams, Neoplasm, Science, Physician, European Union, Systematic review, Research, Accreditation, NICE, UCL, Lymph, Heart, Sentinel lymph node, Allergy, Hospital, Health, Multimedia, England, Methylene blue, Magnetism, Meta-analysis, NHS, Risk, Radionuclide, PLOS One, Patient, CEO, North Manchester, North Manchester General Hospital, Breast cancer, Woman, National Institute, Technology, University College London, Medical imaging, Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology

Endomags lymphatic tracer, Magtrace, has received an accreditation from the National Institute for Health and Care Excellence (NICE) for locating sentinel lymph nodes.

Key Points: 
  • Endomags lymphatic tracer, Magtrace, has received an accreditation from the National Institute for Health and Care Excellence (NICE) for locating sentinel lymph nodes.
  • To determine if breast cancer has spread, doctors analyse the sentinel, or nearest, lymph nodes to the tumour to see if they contain cancer cells.
  • Unlike technetium-99m, the Magtrace lymphatic tracer is manufactured in the UK and requires no nuclear facilities to be stored or used.
  • Endomag welcomes NICEs accreditation of the Magtrace lymphatic tracer and will continue to work to support access and improve standards of care for all breast cancer patients.

Global Methylene Chloride Market (2021 to 2026) - Growth, Trends, COVID-19 Impact, and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, May 28, 2021
Chemicals, Plastics, Manufacturing, Chemistry, Physical sciences, Natural sciences, Organic chemistry, Climate change mitigation, Dichloromethane, Methylene, Methylene blue

Methylene chloride is mainly used to extract several compounds and is also used in the production of antibiotics and vitamins.

Key Points: 
  • Methylene chloride is mainly used to extract several compounds and is also used in the production of antibiotics and vitamins.
  • Therefore, the increasing pharmaceutical industry is expected to propel the demand for methylene chloride during the forecast period.
  • Asia-Pacific region is expected to account for the largest market for methylene chloride during the forecast period.
  • Hence, with such trends, the demand for methylene chloride in the Asia-Pacific region is expected to grow during the forecast period.